STORY
EU Regulator Backs Twice-Yearly HIV Prevention Injection
Last updated 9 months ago
STORY
Global Drug Bust Seizes $65M in Counterfeit Medicines
Last updated 10 months ago
STORY
Four States Petition FDA to Lift Abortion Pill Restrictions
Last updated 10 months ago
STORY
EU Regulators Find Wegovy, Ozempic Link to Rare Vision Loss
Last updated 10 months ago
STORY
Trump Orders Significant Drug Price Cuts
Last updated 11 months ago
STORY
US Drug Tariffs Could Trigger $51B Price Surge, Industry Warns
Last updated 12 months ago
STORY
White House Pulls CDC Nominee
Last updated 13 months ago
STORY
Biden Admin. Proposes Expanding Coverage of Weight-Loss Drugs
Last updated 15 months ago
STORY
GSK to Pay $2.2B to Settle Zantac Cancer Lawsuits
Last updated 15 months ago
STORY
Pfizer Recalls Sickle Cell Treatment
Last updated 15 months ago
STORY
Study: Highly-Affordable 'Vaccine-Like' HIV Drug Possible
Last updated 15 months ago
STORY
Eli Lilly to Buy Morphic for $3.2B
Last updated 15 months ago
STORY
Eli Lilly Sues Alleged Purveyors of Counterfeit Mounjaro
Last updated 15 months ago
Why scientists are nervous about fungi
NPR Online News #3 - 21 hours ago
NPR Online News #3 - 21 hours agoNew evidence links heart disease to inflammation—and drugs can stop it
Scientific American #1 - 2 weeks ago
Scientific American #1 - 2 weeks agoOpinion | GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Up
New York Times #1 - 1 day ago
New York Times #1 - 1 day agoHow Merck keeps prices for its blockbuster cancer drug sky high
USA Today #1 - 3 days ago
USA Today #1 - 3 days agoQuit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it
NPR Online News #1 - 3 days ago
NPR Online News #1 - 3 days agoMassive eye drop recall reflects ongoing issues with manufacturing and FDA inspection
The Conversation #2 - 10 days ago
The Conversation #2 - 10 days agoHow well GLP-1 weight loss drugs work may depend on your genetics
Scientific American #3 - 11 hours ago
Scientific American #3 - 11 hours agoAmerica Has a New GLP-1 Playbook
Atlantic #2 - 6 days ago
Atlantic #2 - 6 days agoMultipurpose anti-viral pill may treat colds, norovirus, flu and covid
New Scientist #2 - 2 weeks ago
New Scientist #2 - 2 weeks agoRFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.
ProPublica #1 - 32 minutes ago
ProPublica #1 - 32 minutes agoA single course of antibiotics may reshape the gut microbiome for years
Scientific American #1 - 4 weeks ago
Scientific American #1 - 4 weeks agoDrugmakers raised prices on hundreds of drugs despite Trump deals, Senate Democrats report finds
NBC #13 - 1 day ago
NBC #13 - 1 day agoFresh understanding of the causes of migraine reveals new drug targets
New Scientist #1 - 3 weeks ago
New Scientist #1 - 3 weeks agoJapan Approves the World’s First Treatment Made With Reprogrammed Human Cells
Wired #1 - 4 weeks ago
Wired #1 - 4 weeks agoFDA wants to make more drugs available over the counter, but experts have raised safety concerns
Scientific American #1 - 3 weeks ago
Scientific American #1 - 3 weeks agoFDA will consider easing restrictions on peptides as RFK Jr. calls himself a "big fan"
CBS #12 - 2 days ago
CBS #12 - 2 days agoFDA approves GLP-1 weight loss pill Foundayo from Eli Lilly
NBC #6 - 2 weeks ago
NBC #6 - 2 weeks agoFDA Approves Eli Lilly’s GLP-1 Pill
Wired #3 - 2 weeks ago
Wired #3 - 2 weeks agoWegovy Weight-Loss Pills Hit U.S. Pharmacies—Costs and Treatments Explained
Scientific American #1 - 2 months ago
Scientific American #1 - 2 months agoPharma giants AbbVie and Genentech join TrumpRx Hub under admin’s ‘Most-Favored-Nation’ pricing
One America #1 - 21 hours ago
One America #1 - 21 hours agoFDA to weigh easing limits on unproven peptides promoted by RFK Jr.
NBC #13 - 2 days ago
NBC #13 - 2 days agoNo Broad Autism Approval for Leucovorin, Despite FDA Commissioner’s Prior Suggestions
Factcheck #1 - 9 days ago
Factcheck #1 - 9 days agoWegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.
Scientific American #1 - 3 months ago
Scientific American #1 - 3 months agoMedvi, the AI-powered telehealth company, is fueled by ads from doctors who don't appear to exist
Business Insider #8 - 2 weeks ago
Business Insider #8 - 2 weeks agoAntibiotic resistance could undo a century of medical progress – but four advances are changing the story
The Conversation #1 - 2 months ago
The Conversation #1 - 2 months agoA revolutionary way to map our bodies is helping cure deadly diseases
New Scientist #1 - 2 months ago
New Scientist #1 - 2 months agoHeart and Kidney Diseases, plus Type 2 Diabetes, May Be One Illness Treatable with Ozempic-like Drugs
Scientific American #1 - 2 months ago
Scientific American #1 - 2 months ago
